Downregulation of CD9 in Keratinocyte Contributes to Cell Migration via Upregulation of Matrix Metalloproteinase-9

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Jiang, Xu pin ^a   Zhang, Dong xia ^a   Teng, Miao ^b   Zhang, Qiong ^a   Zhang, Jia ping ^a   Huang, Yue sheng ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CD9 ANTIGEN; GELATINASE A; GELATINASE B; MESSENGER RNA; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CELL LINE; CELL MIGRATION; CELL PROLIFERATION; CELL STRAIN HACAT; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; KERATINOCYTE; MOUSE; NEWBORN; NONHUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; WOUND; WOUND HEALING; ZYMOGRAPHY;

ANIMALS; ANTIGENS, CD9; BLOTTING, WESTERN; CELL LINE; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINOCYTES; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED BALB C; MICROSCOPY, FLUORESCENCE; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84885815663     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0077806     Document Type: Article

References (50)

1. Stipp CS, Kolesnikova TV, Hemler ME, (2003) Functional domains in tetraspanin proteins. Trends Biochem Sci 28: 106-112. doi:10.1016/S0968-0004(02)00014-2. PubMed: 12575999.
2. Boucheix C, Rubinstein E, (2001) Tetraspanins. Cell Mol Life Sci 58: 1189-1205. doi:10.1007/PL00000933. PubMed: 11577978.
3. Hemler ME, (2005) Tetraspanin functions and associated microdomains. Nat Rev Mol Cell Biol 6: 801-811. doi:10.1038/nrg1738. PubMed: 16314869.
4. Miyake M, Inufusa H, Adachi M, Ishida H, Hashida H, et al. (2000) Suppression of pulmonary metastasis using adenovirally motility related protein-1 (MRP-1/CD9) gene delivery. Oncogene 19: 5221-5226. doi:10.1038/sj.onc.1203919. PubMed: 11077438.
5. Powner D, Kopp PM, Monkley SJ, Critchley DR, Berditchevski F, (2011) Tetraspanin CD9 in cell migration. Biochem Soc Trans 39: 563-567. doi:10.1042/BST0390563. PubMed: 21428940.
6. Masellis-Smith A, Shaw AR, (1994) CD9-regulated adhesion. Anti-CD9 monoclonal antibody induce pre-B cell adhesion to bone marrow fibroblasts through de novo recognition of fibronectin. J Immunol 152: 2768-2777. PubMed: 7511626.
7. García-López MA, Barreiro O, García-Díez A, Sánchez-Madrid F, Peñas PF, (2005) Role of tetraspanins CD9 and CD151 in primary melanocyte motility. J Invest Dermatol 125: 1001-1009. doi:10.1111/j.0022-202X.2005.23882.x. PubMed: 16297202.
8. Deissler H, Kuhn EM, Lang GE, (2007) Tetraspanin CD9 is involved in the migration of retinal microvascular endothelial cells. Int J Mol Med 20: 643-652. PubMed: 17912457.
9. Anton ES, Hadjiargyrou M, Patterson PH, Matthew WD, (1995) CD9 plays a role in Schwann cell migration in vitro. J Neurosci 15: 584-595. PubMed: 7529830.
10. Peñas PF, García-López MA, Barreiro del Río O, (2005) Inhibition of the motility of melanoma cells using interference RNA against CD9. Actas Dermosifiliogr 96: 30-36. doi:10.1016/S0001-7310(05)73029-5. PubMed: 16476329.
11. Fan J, Zhu GZ, Niles RM, (2010) Expression and function of CD9 in melanoma cells. Mol Carcinog 49: 85-93. PubMed: 19777564.
12. Martin P, (1997) Wound healing--aiming for perfect skin regeneration. Science 276: 75-81. doi:10.1126/science.276.5309.75. PubMed: 9082989.
13. Sincock PM, Mayrhofer G, Ashman LK, (1997) Localization of the transmembrane 4 superfamily (TM4SF) member PETA-3 (CD151) in normal human tissues: comparison with CD9, CD63, and alpha5beta1 integrin. J Histochem Cytochem 45: 515-525. doi:10.1177/002215549704500404. PubMed: 9111230.
14. Zhang JP, Dong JD, Gu H, Yu S, Zhang XH, et al. (2012) CD9 Is Critical for Cutaneous Wound Healing through JNK Signaling. J Invest Dermatol 132: 226-236. doi:10.1038/jid.2011.268. PubMed: 21881583.
15. Gurtner GC, Werner S, Barrandon Y, Longaker MT, (2008) Wound repair and regeneration. Nature 453: 314-321. doi:10.1038/nature07039. PubMed: 18480812.
16. Aarabi S, Longaker MT, Gurtner GC, (2007) Hypertrophic scar formation following burns and trauma: new approaches to treatment. PLOS Med 4: e234. doi:10.1371/journal.pmed.0040234. PubMed: 17803351.
17. Sternlicht MD, Werb Z, (2001) How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 17: 463-516. doi:10.1146/annurev.cellbio.17.1.463. PubMed: 11687497.
18. Chen JS, Huang XH, Wang Q, Huang JQ, Zhang LJ, et al. (2013) Sonic hedgehog signaling pathway induces cell migration and invasion through focal adhesion kinase/AKT signaling-mediated activation of matrix metalloproteinase (MMP)-2 and MMP-9 in liver cancer. Carcinogenesis 34: 10-19. doi:10.1093/carcin/bgs274. PubMed: 22948179.
19. Ravanti L, Kähäri VM, (2000) Matrix metalloproteinases in wound repair (review). Int J Mol Med 6: 391-407 PubMed: 10998429.
20. Santoro MM, Gaudino G, (2005) Cellular and molecular facets of keratinocyte reepithelization during wound healing. Exp Cell Res 304: 274-286. doi:10.1016/j.yexcr.2004.10.033. PubMed: 15707592.
21. Coussens LM, Tinkle CL, Hanahan D, Werb Z, (2000) MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 103: 481-490. doi:10.1016/S0092-8674(00)00139-2. PubMed: 11081634.
22. Kähäri VM, Saarialho-Kere U, (1997) Matrix metalloproteinases in skin. Exp Dermatol 6: 199-213. doi:10.1111/j.1600-0625.1997.tb00164.x. PubMed: 9450622.
23. Reiss MJ, Han YP, Garcia E, Goldberg M, Yu H, et al. (2010) Matrix metalloproteinase-9 delays wound healing in a murine wound model. Surgery 147: 295-302. doi:10.1016/j.surg.2009.10.016. PubMed: 20004432.
24. Kyriakides TR, Wulsin D, Skokos EA, Fleckman P, Pirrone A, et al. (2009) Mice that lack matrix metalloproteinase-9 display delayed wound healing associated with delayed reepithelization and disordered collagen fibrillogenesis. Matrix Biol 28: 65-73. doi:10.1016/j.matbio.2009.01.001. PubMed: 19379668.
25. Kotha J, Herr M, Jennings LK, (2010) CD9 Regulates Arterial Smooth Muscle Cell Morphology and Alters Contractile Protein and MMP-9 Expression. Arterioscler Thromb Vasc Biol 30: E263-E263.
26. Hong IK, Kim YM, Jeoung DI, Kim KC, Lee H, (2005) Tetraspanin CD9 induces MMP-2 expression by activating p38 MAPK, JNK and c-Jun pathways in human melanoma cells. Exp Mol Med 37: 230-239. doi:10.1038/emm.2005.31. PubMed: 16000878.
27. Zheng M, Li CM, Li W, Man XY, Zhou JO, et al. (2011) Pigment epithelium-derived factor plays an inhibitory role in proliferation and migration of HaCaT cells. Mol Biol Rep 38: 2099-2105. doi:10.1007/s11033-010-0336-3. PubMed: 20857208.
28. Kim S, Kim Y, Lee Y, Cho KH, Kim KH, et al. (2007) Cholesterol inhibits MMP-9 expression in human epidermal keratinocytes and HaCaT cells. FEBS Lett 581: 3869-3874. doi:10.1016/j.febslet.2007.06.074. PubMed: 17643435.
29. Raja, Sivamani K, Garcia MS, Isseroff RR, (2007) Wound re-epithelialization: modulating keratinocyte migration in wound healing. Front Biosci 12: 2849-2868. doi:10.2741/2277. PubMed: 17485264.
30. Kirfel G, Herzog V, (2004) Migration of epidermal keratinocytes: mechanisms, regulation, and biological significance. Protoplasma 223: 67-78. PubMed: 15221512.
31. Zhang Q, Tan D, Luo W, Lu J, Tan Y, (2012) Expression of CD82 in human trophoblast and its role in trophoblast invasion. PLOS ONE 7: e38487-e38487. doi:10.1371/journal.pone.0038487. PubMed: 22679510.
32. Gutiérrez-López MD, Gilsanz A, Yáñez-Mó M, Ovalle S, Lafuente EM, et al. (2011) The sheddase activity of ADAM17/TACE is regulated by the tetraspanin CD9. Cell Mol Life Sci 68: 3275-3292. doi:10.1007/s00018-011-0639-0. PubMed: 21365281.
33. Xue M, Jackson CJ, (2008) Autocrine actions of matrix metalloproteinase (MMP)-2 counter the effects of MMP-9 to promote survival and prevent terminal differentiation of cultured human keratinocytes. J Invest Dermatol 128: 2676-2685. doi:10.1038/jid.2008.136. PubMed: 18496568.
34. Rayment EA, Upton Z, Shooter GK, (2008) Increased matrix metalloproteinase-9 (MMP-9) activity observed in chronic wound fluid is related to the clinical severity of the ulcer. Br J Dermatol 158: 951-961. doi:10.1111/j.1365-2133.2008.08462.x. PubMed: 18284390.
35. Ekekezie II, Thibeault DW, Simon SD, Norberg M, Merrill JD, et al. (2004) Low levels of tissue inhibitors of metalloproteinases with a high matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio are present in tracheal aspirate fluids of infants who develop chronic lung disease. Pediatrics 113: 1709-1714. doi:10.1542/peds.113.6.1709. PubMed: 15173495.
36. Schönbeck U, Mach F, Libby P, (1998) Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 beta processing. J Immunol 161: 3340-3346. PubMed: 9759850.
37. Orlando S, Sironi M, Bianchi G, Drummond AH, Boraschi D, et al. (1997) Role of metalloproteases in the release of the IL-1 type II decoy receptor. J Biol Chem 272: 31764-31769. doi:10.1074/jbc.272.50.31764. PubMed: 9395521.
38. Gutiérrez-Fernández A, Inada M, Balbín M, Fueyo A, Pitiot AS, et al. (2007) Increased inflammation delays wound healing in mice deficient in collagenase-2 (MMP-8). FASEB J 21: 2580-2591. doi:10.1096/fj.06-7860com. PubMed: 17392479.
39. Klein-Soyer C, Azorsa DO, Cazenave JP, Lanza F, (2000) CD9 Participates in Endothelial Cell Migration During In Vitro Wound Repair. Arterioscler Thromb Vasc Biol 20: 360-369. doi:10.1161/01.ATV.20.2.360. PubMed: 10669631.
40. O'Toole EA, van Koningsveld R, Chen M, Woodley DT, (2008) Hypoxia induces epidermal keratinocyte matrix metalloproteinase-9 secretion via the protein kinase C pathway. J Cell Physiol 214: 47-55. doi:10.1002/jcp.21160. PubMed: 17559070.
41. Thomas GJ, Poomsawat S, Lewis MP, Hart IR, Speight PM, et al. (2001) alpha v beta 6 Integrin upregulates matrix metalloproteinase 9 and promotes migration of normal oral keratinocytes. J Invest Dermatol 116: 898-904.
42. Lu CY, Lai SC, (2013) Matrix metalloproteinase-2 and-9 lead to fibronectin degradation in astroglia infected with Toxoplasma gondii. Acta Trop 125: 320-329. doi:10.1016/j.actatropica.2012.11.002. PubMed: 23201304.
43. Karroum A, Mirshahi P, Benabbou N, Faussat A-M, Soria J, et al. (2010) Matrix metalloproteinase-9 is required for tubular network formation and migration of resistant breast cancer cells MCF-7 through PKC and ERK1/2 signalling pathways. Cancer Lett 295: 242-251. doi:10.1016/j.canlet.2010.03.007. PubMed: 20359813.
44. Hsu JYC, Bourguignon LYW, Adams CM, Peyrollier K, Zhang H, et al. (2008) Matrix Metalloproteinase-9 Facilitates Glial Scar Formation in the Injured Spinal Cord. J Neurosci 28: 13467-13477. doi:10.1523/JNEUROSCI.2287-08.2008. PubMed: 19074020.
45. Hemler ME, (2008) Targeting of tetraspanin proteins--potential benefits and strategies. Nat Rev Drug Discov 7: 747-758. doi:10.1038/nrd2659. PubMed: 18758472.
46. Bassani S, Cingolani LA, (2012) Tetraspanins: Interactions and interplay with integrins. Int J Biochem Cell Biol 44: 703-708. doi:10.1016/j.biocel.2012.01.020. PubMed: 22326999.
47. Peñas PF, García-Díez A, Sánchez-Madrid F, Yáñez-Mó M, (2000) Tetraspanins are localized at motility-related structures and involved in normal human keratinocyte wound healing migration. J Invest Dermatol 114: 1126-1135. doi:10.1046/j.1523-1747.2000.00998.x. PubMed: 10844555.
48. Baudoux B, Castanares-Zapatero D, Leclercq-Smekens M, Berna N, Poumay Y, (2000) The tetraspanin CD9 associates with the integrin alpha6beta4 in cultured human epidermal keratinocytes and is involved in cell motility. Eur J Cell Biol 79: 41-51. doi:10.1078/S0171-9335(04)70006-0. PubMed: 10711425.
49. Germain L, Rouabhia M, Guignard R, Carrier L, Bouvard V, et al. (1993) Improvement of human keratinocyte isolation and culture using thermolysin. Burns 19: 99-104. doi:10.1016/0305-4179(93)90028-7. PubMed: 8471157.
50. Liang CC, Park AY, Guan JL, (2007) In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc 2: 329-333. doi:10.1038/nnano.2007.164. PubMed: 17406593.